We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A Key Advancement in Cancer Sequencing

Product News   Oct 28, 2016

 
A Key Advancement in Cancer Sequencing
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Biopharma Receives Positive EMA Opinion on Orphan Designation for Pancreatic Cancer Treatment

Product News

Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the European Medicines Agency (EMA) Orphan Drug Commission (COMP) has granted a positive opinion for an Orphan Drug Designation (ODD) status to its first-in-class anti-PAUF monoclonal antibody, PBP1510, for the treatment of pancreatic cancer.

READ MORE

Daicel Arbor Biosciences Introduces myBaits® Custom Methyl-Seq

Product News

Daicel Arbor Biosciences, a division of Chiral Technologies, Inc., announces the launch of their new line of myBaits Custom Methyl-Seq target capture kits. This pairs an innovative methyl-seq probe design algorithm with a highly optimized target capture protocol to efficiently enrich target genes and markers of interest from converted methyl-seq NGS libraries.

READ MORE

Canada’s Largest Research Hospital Selects ImmunoGenomiX Platform To Analyze Immune Sequencing Data

Product News

ENPICOM, an innovative bioinformatics software engineering company specialized in decoding the immune system, announced that the Princess Margaret Cancer Centre of the University Health Network (UHN) has purchased a subscription to ENPICOM’s data analysis platform.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE